Healwell Pharmaceuticals was founded by Prof. Dato’ Dr. Hassan Yaacob, when he was still a Researcher at University Malaya. After many years of intensive R&D into the benefits of gamat, he turned entrepreneur and commercialised gamat and gamat- based products. He is a PhD holder in Clinical Pharmacology from Royal College of Surgeons of England, London. He is also an Executive Chairman/CEO of the Company.
Healwell Pharmaceuticals was established in 1996 to manufacture and market gamat and its by-products on a commercial basis. Gamat is a type of sea cucumber found in abundance in the waters off the shores of Langkawi, Kedah.
After more than 10 years of R&D, Healwell Pharmaceuticals was able to market its products under the brand name of HEALIN in Malaysia.
Over the years, the company has placed itself as a leading Bumiputra Company that markets high quality, trusted, ethical and halal natural-based products. Through extensive R&D, the products were proven to enhance the body’s resistance towards various diseases besides having a cell growth factor.
Healwell Pharmaceuticals has gained a reputation as a respected company, known for the introduction of new concepts of health and skin care focusing specially on sophistication, simple yet effective.
Address:
NO.1, JALAN KARTUNIS U1/47,
SEK U1, TEMASYA INDUSTRIAL PARK,
40150 SHAH ALAM
SELANGOR.
Tel : 03-5569 5580
Fax : 03-5569 5581
EMAIL : info@healwell.com.my
“Clinical trials are an area where we want to build capabilities, both internally and externally” says Novartis Malaysia’s president and managing director. Novartis, with 22 ongoing trials, is one of…
“Clinical trials are an area where we want to build capabilities, both internally and externally” says Novartis Malaysia’s president and managing director. Novartis, with 22 ongoing trials, is one of…
“Clinical trials are an area where we want to build capabilities, both internally and externally” says Novartis Malaysia’s president and managing director. Novartis, with 22 ongoing trials, is one of…
Klinsel’s CEO discusses the company’s ambitions of growth in a very competitive CRO market and stresses that local experience is truly a distinguishing factor and this is why they are…
Novo Nordisk Malaysia’s general manager shares the ongoing fight to cure diabetes and talks about the necessity to raise awareness, with for instance their current MoU with the ministry of…
Malaysia Healthcare Travel Council’s CEO is proud of her country’s healthcare system and their efforts at attracting medical tourists from all over the world, with the support of the healthcare…
Mundipharma Malaysia’s country manager discusses his company’s aim to become a reference in Malaysia for pain management, on the back of the tremendous 48 percent growth of the business last year. …
Lundbeck’s country manager gives a thorough overview of CNS disorders in Malaysia and states: “It is important to remind everyone that mental health conditions or brain diseases are not to…
MMA’s president shares the reasons why Malaysia is ranked today third in terms of healthcare quality, with a very efficient public system, high quality doctors and strong government support. However,…
IMS in Malaysia is possibly the first company to have signed a Memorandum of Understanding with the government for data provision. IMS Health’s general manager introduces this landmark and also…
Aspen Malaysia’s country manager details the company’s success in the country with a specific business model based on acquiring and remarketing originators. Although Aspen is a renowned generic player, market dynamics…
MGCC’s Executive Director discusses the opportunities and challenges for German pharma and healthcare companies to invest in Malaysia, at a time where most have decided to invest and base their…
See our Cookie Privacy Policy Here
